Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis

被引：0
|
作者：
Peng Men
Shuli Qu
Zhenqiang Song
Yanjun Liu
Chaoyun Li
Suodi Zhai
机构：
[1] Peking University Third Hospital,Department of Pharmacy
[2] Peking University Health Science Center,Institute for Drug Evaluation
[3] IQVIA,Real
[4] Tianjin Medical University Chu Hisen-I Memorial Hospital,World Insights Division
[5] Sanofi,Health Economics and Outcome Research
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Chinese; Economics; GLP-1 analogue; Network meta-analysis; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1745 / 1755
页数：10
相关论文
共 50 条
  • [21] Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus: A network meta-analysis based on randomized controlled trials
    Wu, Qian
    Liu, Miaowen
    Fang, Zige
    Li, Chenxi
    Zou, Fang
    Hu, Lei
    Zhang, Wenxiong
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (03) : 270 - 286
  • [22] Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta-analysis
    Shen, Yi
    Zhang, Sheng
    Wang, Xulin
    Wang, Yuanyuan
    Zhang, Jian
    Qin, Gang
    Li, Wenchao
    Ding, Kun
    Zhang, Lei
    Liang, Feng
    LIVER INTERNATIONAL, 2017, 37 (10) : 1451 - 1460
  • [23] Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials
    Al Yami, Majed S.
    Alfayez, Osamah M.
    Alsheikh, Razan
    HEART LUNG AND CIRCULATION, 2018, 27 (11) : 1301 - 1309
  • [24] Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis
    Li, Xuefeng
    Wu, Hongli
    Peng, Huifang
    Jiang, Hongwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective
    Chuang, L. H.
    Verheggen, B. G.
    Charokopou, M.
    Gibson, D.
    Grandy, S.
    Kartman, B.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (12) : 1127 - 1134
  • [26] Comparison of New Glucose-Lowering Drugs on the Risk of Pancreatitis in Type 2 Diabetes: A Network Meta-Analysis
    Zhang, Xuexue
    Wang, Miaoran
    Wang, Xujie
    Zhu, Zhengchuan
    Zhang, Wantong
    Zhou, Zhongyang
    Tang, Wei
    Li, Qiuyan
    ENDOCRINE PRACTICE, 2022, 28 (03) : 333 - 341
  • [27] Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes
    Zaazouee, Mohamed Sayed
    Hamdallah, Aboalmagd
    Helmy, Sara Kamel
    Hasabo, Elfatih A.
    Sayed, Ahmed Kamal
    Gbreel, Mohamed Ibrahim
    Abd Elmegeed, Aya
    Aladwan, Hala
    Elshanbary, Alaa Ahmed
    Abdel-Aziz, Walid
    Elshahawy, Israa Mohamed
    Rabie, Shehab
    Elkady, Sherouk
    Ali, Ahmed Said
    Ragab, Khaled Mohamed
    Nourelden, Anas Zakarya
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (06)
  • [28] Meta-Analysis of the Therapeutic Effect of Shenqi Jiangtang Granule on Type 2 Diabetes Mellitus
    Li, Ruo-Lan
    Dong, Tai-Wei
    Wei, Ji-Gang
    Gao, Feng
    Li, Min
    Bai, Yang
    Wei, Pei-Feng
    Xi, Miao-Miao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [29] Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis
    Htike, Zin Z.
    Zaccardi, Francesco
    Papamargaritis, Dimitris
    Webb, David R.
    Khunti, Kamlesh
    Davies, Melanie J.
    DIABETES OBESITY & METABOLISM, 2017, 19 (04) : 524 - 536
  • [30] DPP-4 Inhibitor Treatment in Chinese Type 2 Diabetes Patients: A Meta-Analysis
    Cai, Xiaoling
    Gao, Xueying
    Yang, Wenjia
    Chen, Yifei
    Zhou, Lingli
    Zhang, Simin
    Han, Xueyao
    Ji, Linong
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (12) : 784 - 793
12345